German officials have decided to limit the use of AstraZeneca’s coronavirus vaccine in people younger than 60 after more unusual blood clots were reported.
Last month, more than a dozen countries, including Germany, suspended their use of AstraZeneca over the blood clot issue. Most restarted some with age restrictions after the EMA said the benefits of the vaccine outweighed the risks of not inoculating people against COVID-19. The Amsterdam-based agency said there was no evidence of an overall increased risk of blood clots, but it recommended that the vaccine’s leaflet be updated to inform doctors and patients about the rare clots.
Official says EU agency to confirm AstraZeneca blood clot link stripes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stripes.com Daily Mail and Mail on Sunday newspapers.
A top official at the European Medicines Agency said in an interview published Tuesday there is a causal link between AstraZeneca s coronavirus vaccine and rare blood clots, but that it s still unclear what the connection is and the benefits of taking the vaccine outweigh the risks of getting COVID-19. Marco Cavaleri, head of health threats and vaccine strategy at the Amsterdam-based agency, told Rome s Il Messaggero newspaper that the EU medicines regulator is preparing to make a more definitive statement this week. Based on the evidence to date, Cavaleri said there s a clear association between the AstraZeneca vaccine and the dozens of rare blood clots that have been reported worldwide amid the tens of millions of vaccine jabs that have been given out.
Official: EU agency to confirm AstraZeneca blood clot link msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.